John Marshall Bancorp (JMSB) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
12 Aug, 2025Executive summary
Net income for the six months ended June 30, 2025 was $9.9 million, up 22.2% year-over-year; Q2 2025 net income was $5.1 million, up 30.7% year-over-year; diluted EPS rose 21.0% to $0.69 for six months and 33.3% to $0.36 for Q2.
Pre-tax, pre-provision earnings (Non-GAAP) increased 50.7% year-over-year to $7.1 million in Q2 2025.
Book value per share increased 7.8% year-over-year to $17.83; shareholders' equity rose 7.8% to $253.7 million.
Strong loan demand with $135.5 million in new commitments, the highest since Q4 2022.
Asset quality remained excellent with no nonperforming assets, no nonaccrual loans, and no net charge-offs as of June 30, 2025.
Financial highlights
Net interest income increased 21.8% to $29.0 million for the six months and 23.5% to $14.9 million for Q2 2025.
Net interest margin (tax-equivalent) improved to 2.64% for the six months and 2.70% for Q2 2025.
Return on average assets was 0.89% for six months and 0.91% for Q2 2025; return on average equity was 7.91% for six months and 8.06% for Q2 2025.
Efficiency ratio improved to 55.1% for six months and 53.9% for Q2 2025.
Non-interest income declined 26.3% to $1.0 million for six months; non-interest expense increased 4.6% to $16.6 million, mainly from higher salaries and data processing.
Outlook and guidance
Management expects continued loan and net interest income growth, supported by a strong loan pipeline and robust asset quality.
Capital and liquidity positions are expected to support further growth and returns.
No material changes in risk factors or forward-looking statements since the last annual report.
Latest events from John Marshall Bancorp
- Earnings and loan growth surged, with improved margins and strong asset quality in Q4 2025.JMSB
Q4 202528 Jan 2026 - Flexible $80M shelf registration enables diverse securities offerings amid regional focus and risk.JMSB
Registration Filing16 Dec 2025 - Annual meeting to elect directors, ratify auditor, and approve new stock incentive plan.JMSB
Proxy Filing2 Dec 2025 - Key votes include director elections, auditor ratification, and a new stock incentive plan.JMSB
Proxy Filing2 Dec 2025 - Net income up 24.1% Y/Y to $15.3M and 27.6% in Q3, with strong loan growth and no nonperforming assets.JMSB
Q3 202514 Nov 2025 - Net income declined 24.9% year-over-year, with Q2 at $3.9M and strong asset quality.JMSB
Q2 20249 Oct 2025 - Net income and book value per share rose, with strong margins and pristine asset quality.JMSB
Q3 202413 Jun 2025 - Q1 net income up 14.4% with robust margin, asset quality, and a 20% dividend hike.JMSB
Q1 20256 Jun 2025 - Q4 net income up, margins and loan growth strong, with robust capital and asset quality.JMSB
Q4 20245 Jun 2025